Skip to Main Navigation Skip to Main Content Skip to Footer

The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.

  • About Stem Cells
  • Donate
  • Join

The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.

  • About ISSCR
    • History & Philosophy
    • ISSCR Leadership
      • Officers & Board of Directors
      • ISSCR Committees
    • ISSCR Staff
    • Awards
      • ISSCR Outstanding Young Investigator Award
      • ISSCR Achievement Award
      • ISSCR Momentum Award
      • Public Service Award
      • Zhongmei Chen Yong Awards for Scientific Excellence
      • Poster Awards
      • Merit Abstract Awards
      • ISSCR Tobias Award Lecture
      • ISSCR Award for Innovation
    • Circle of Stem Cell Institute and Center Directors
    • Donate
    • Contact Us
  • Membership
    • Join or Renew
    • Update Your Profile
    • Member Spotlight
    • Nominations for the Board of Directors
    • 2022 Election Results
  • Meetings & Events
    • Annual Meetings
      • About Annual Meetings
      • ISSCR Annual Meeting 2023
      • ISSCR Annual Meeting 2022
    • International Symposia
      • About International Symposia
      • Madison 2022 Symposium
      • Boston 2022 Symposium
    • ISSCR Digital
      • About ISSCR Digital
      • Spatial Transcriptomics
      • Cellular Barcoding
      • Speaker's Corner
    • Non-ISSCR Meetings & Courses
    • Code of Conduct for ISSCR Meetings and Events
  • Policy & Advocacy
    • Guidelines
    • Lawrence Goldstein Science Policy Fellowship Program
    • Positions and Statements
    • Annual Advocacy Day
  • News & Publications
    • Stem Cell Reports
      • Journal Homepage
      • Editors
      • Editorial Board
    • Podcast - The Stem Cell Report
    • ISSCR News Digital Newsletter
    • Press Releases/Statements
    • Stem Cells in Focus - Blog
    • News from ISSCR
    • Advertise with the ISSCR
    • Early Career Scientist Editorial Board
  • Careers
    • Job Board
    • Jobs with the ISSCR
    • Career Development Videos
    • Funding Resources
    • Women in Science
  • Resources
    • Scientific Resources
    • Clinical Resources
    • Education Resources
    • Patient Resources
    • Stem Cell Institutes and Centers
    • COVID-19 Resources for the Stem Cell Community
      • Covid 19 Networking & Meetings
    • ISSCR COVID-19 Survey Results
  • Home
  • News & Publications
  • News Articles
  • Member News Items
  • Policy News
  • Press Releases/Statements
      • 1 November, 2016

    ISSCR Comments to Australian Therapeutic Goods Administration on Regulation of Autologous Cell and Tissue Products

    In comments to the Australian Therapeutic Goods Administration (TGA), the ISSCR supported regulation of autologous products that involve more than minimal manipulation of a patient’s cells and place strict limitations on the direct advertisement of cell-based therapies. The comments were in response to the TGA's call for input from interested parties about the regulation of autologous cell and tissue products.
    Full story
      • 15 September, 2016

    ISSCR Opposes the REGROW Act

    The ISSCR opposes the REGROW Act, which would allow certain cell and tissue-based therapeutics to be marketed without first providing rigorous evidence of safety and efficacy. If passed, this legislation could negatively impact the development of stem cell therapies, the integrity of the emerging regenerative medicine market, and the health and safety of people using stem cell products approved under this Act.
    Full story
      • 13 September, 2016

    ISSCR Comments Before FDA Panel on Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products

    The ISSCR today underscored the need for careful oversight and regulation of stem cell research at every stage in the process of developing therapeutic products for patient use.
    Full story
      • 7 September, 2016

    ISSCR Comments Regarding Proposed Changes to the U.S. National Institutes of Health Guidelines on Human Stem Cell Research

    The ISSCR supports the continued assessment of the U.S. National Institutes of Health (NIH) Guidelines for Human Stem Cell Research. We applaud the proposed end to the current moratorium on U.S. federal funding of human-animal chimera research involving the introduction of human pluripotent cells into early stage animal embryos.
    Full story
      • 8 August, 2016

    ISSCR Favors NIH Proposal on Human-Animal Chimera Research

    The ISSCR is pleased that the U.S. National Institutes of Health (NIH) is considering an end to the moratorium on NIH funding of human-animal chimera research (NIH Notice, 8-4-16).
    Full story
      • 7 July, 2016

    ISSCR Submits Comments to NAS Regarding Human Gene Editing

    The ISSCR provided comments to the National Academy of Science/National Academy of Medicine Committee on Human Gene Editing regarding scientific, medical, and ethical considerations.
    Full story
      • 12 May, 2016

    ISSCR Releases Updated Guidelines for Stem Cell Research and Clinical Translation

    The ISSCR, the world’s largest professional organization of stem cell scientists, today released newly updated guidelines for stem cell research and the development of new clinical therapies. Guidance addresses key scientific, ethical, social, and policy challenges raised by new technologies and emerging areas of stem cell discovery and application.
    Full story
      • 26 February, 2016

    ISSCR Endorses Fetal Tissue Research as Essential

    The International Society for Stem Cell Research (ISSCR) is the world’s leading professional organization of stem cell scientists, representing more than 4,000 members in 45 U.S. states and 65 countries around the world. The ISSCR is opposed to recent efforts to inappropriately limit or prohibit biomedical research using fetal tissue. These proposals, if enacted, would obstruct critical biomedical research and inhibit efforts to improve human health. If enacted in the past, such limits would have delayed or prevented the development of therapies that have saved millions of lives.
    Full story
      • 23 April, 2015

    The ISSCR has Responded to the Publication of Gene Editing Research in Human Embryos

    In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research (ISSCR) has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications.
    Full story
      • 19 March, 2015

    The ISSCR Statement on Human Germline Genome Modification

    The International Society for Stem Cell Research calls for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
    Full story
      • 30 May, 2014

    The ISSCR Welcomes the Response by the EU Commission to Concerns around hESC Research Funding

    The ISSCR welcomes the recent EU Commission’s response to concerns about how funding from the Horizon 2020 EU Research and Innovation program is to be used for human embryonic stem cell research. The ISSCR advocates that all forms of stem cell research are crucial for the advancement of our understanding of human health and disease and for the development of novel treatments.
    Full story
      • 12 September, 2013

    ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients

    The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.
    Full story
      • 22 April, 2013

    ISSCR Emphasizes Importance of Regulatory Oversight for Stem Cell Products for Clinical Use

    The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.
    Full story
      • 9 April, 2013

    ISSCR Voices Concern as Italian Government Authorizes Unproven Stem Cell Therapy

    The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.
    Full story
      • 11 October, 2012

    ISSCR Reaffirms Support for All Forms of Stem Cell Research

    The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.
    Full story
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6 (current)
    • 7
  • About ISSCR
    • History & Philosophy
    • ISSCR Leadership
    • ISSCR Staff
    • Awards
    • Circle of Stem Cell Institute and Center Directors
    • Donate
    • Contact Us
  • Membership
    • Join or Renew
    • Update Your Profile
    • Member Spotlight
    • Nominations for the Board of Directors
    • 2022 Election Results
  • Meetings & Events
    • Annual Meetings
    • International Symposia
    • ISSCR Digital
    • Non-ISSCR Meetings & Courses
    • Code of Conduct for ISSCR Meetings and Events
  • Policy & Advocacy
    • Guidelines
    • Lawrence Goldstein Science Policy Fellowship Program
    • Positions and Statements
    • Annual Advocacy Day
  • News & Publications
    • Stem Cell Reports
    • Podcast - The Stem Cell Report
    • ISSCR News Digital Newsletter
    • Press Releases/Statements
    • Stem Cells in Focus - Blog
    • News from ISSCR
    • Advertise with the ISSCR
    • Early Career Scientist Editorial Board
  • Careers
    • Job Board
    • Jobs with the ISSCR
    • Career Development Videos
    • Funding Resources
    • Women in Science
  • Resources
    • Scientific Resources
    • Clinical Resources
    • Education Resources
    • Patient Resources
    • Stem Cell Institutes and Centers
    • COVID-19 Resources for the Stem Cell Community
    • ISSCR COVID-19 Survey Results
Privacy Policy | Terms of Use
The International Society for Stem Cell Research | Phone: +1 (224) 592-5700 | Email: isscr@isscr.org
©2019 The International Society for Stem Cell Research. All rights reserved.

Connect with Us

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • LinkedIn
  • Podcast